Aadi Bioscience Inc
F:3350
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aadi Bioscience Inc
F:3350
|
US |
|
BMTC Group Inc
OTC:BMTCF
|
CA |
|
Jungheinrich AG
F:JUN3
|
DE |
|
S
|
Shaftesbury Capital PLC
SWB:C20
|
UK |
|
C
|
Chu Kong Shipping Enterprises Group Co Ltd
F:CKW
|
HK |
|
V
|
Vantex Resources Ltd
OTC:VANTF
|
CA |
|
T
|
Tunas Baru Lampung Tbk PT
XMUN:T2L
|
ID |
|
E
|
Enlivex Therapeutics Ltd
F:1BT
|
IL |
|
C
|
Cybin Inc
NEO:HELP
|
CA |
|
M
|
MyMD Pharmaceuticals Inc
F:DQS
|
US |
|
A
|
Asia Standard International Group Ltd
F:BDL1
|
HK |
|
M
|
MPC Muenchmeyer Petersen Capital AG
XMUN:MPCK
|
DE |
|
Organogenesis Holdings Inc
F:2PQ
|
US |
|
Concordia Financial Group Ltd
OTC:CRDIY
|
JP |
|
C
|
CLP Holdings Ltd
XMUN:CLP
|
HK |
|
O
|
Oriental Enterprise Holdings Ltd
XMUN:OPQ
|
HK |
|
Reckon Ltd
F:UVW
|
AU |
|
Lycos Energy Inc
F:G4P0
|
CA |
|
T
|
Tuan Sing Holdings Ltd
SWB:TUS
|
SG |
|
C
|
China Oriental Group Co Ltd
SWB:ORG
|
HK |
Wall St Price Targets
Price Targets Summary
Aadi Bioscience Inc
According to Wall Street analysts, the average 1-year price target for
Aadi Bioscience Inc is 3.97 EUR with a low forecast of 2.1 EUR and a high forecast of 5.45 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Aadi Bioscience Inc's stock price target?
Price Target
3.97
EUR
According to Wall Street analysts, the average 1-year price target for
Aadi Bioscience Inc is 3.97 EUR with a low forecast of 2.1 EUR and a high forecast of 5.45 EUR.
What is the Revenue forecast for Aadi Bioscience Inc?
Projected CAGR
30%
The compound annual growth rate for Revenue over the next 4 years is 30%.